RETRACTION: Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial (Retraction of Vol 95, art no E28097, 2022)

被引：0
|
作者：
Salimian, J.
Ahmadi, A.
Amani, J.
机构：
来源：
JOURNAL OF MEDICAL VIROLOGY | 2024年 / 96卷 / 03期
关键词：
D O I：
10.1002/jmv.29509
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RETRACTED: Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial (Retracted Article)
    Salimian, Jafar
    Ahmadi, Ali
    Amani, Jafar
    Olad, Gholamreza
    Halabian, Raheleh
    Saffaei, Ali
    Arabfard, Masoud
    Nasiri, Mojtaba
    Nazarian, Shahram
    Abolghasemi, Hassan
    Alishiri, Gholamhossein
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [2] Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
    Richmond, Peter
    Hatchuel, Lara
    Dong, Min
    Ma, Brenda
    Hu, Branda
    Smolenov, Igor
    Li, Ping
    Liang, Peng
    Han, Htay Htay
    Liang, Joshua
    Clemens, Ralf
    LANCET, 2021, 397 (10275): : 682 - 694
  • [3] N-protein vaccine is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial
    Rabdano, Sevastyan O.
    Ruzanova, Ellina A.
    Vertyachikh, Anastasiya E.
    Teplykh, Valeriya A.
    Emelyanova, Alla B.
    Rudakov, German O.
    Arakelov, Sergei A.
    Pletyukhina, Iuliia V.
    Saveliev, Nikita S.
    Lukovenko, Anna A.
    Fakhretdinova, Liliya N.
    Safi, Ariana S.
    Zhirenkina, Ekaterina N.
    Polyakova, Irina N.
    Belozerova, Natalia S.
    V. Klykov, Vladislav
    Savelieva, Arina P.
    Ekimov, Aleksey A.
    V. Pokachalov, Konstantin
    Merkulov, Vadim A.
    Yudin, Sergei M.
    Kruchko, Daria S.
    Berzin, Igor A.
    Skvortsova, Veronika I.
    JOURNAL OF INFECTION, 2024, 89 (05)
  • [4] Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial
    Liao, Yuyi
    Li, Yuan
    Pei, Rongjuan
    Fang, Xin
    Zeng, Peiyu
    Fan, Renfeng
    Ou, Zhiqiang
    Deng, Jinglong
    Zhou, Jian
    Guan, Wuxiang
    Min, Yuanqin
    Deng, Fei
    Peng, Hua
    Zhang, Zheng
    Feng, Chunyan
    Xin, Baobao
    He, Jianfeng
    Hu, Zhongyu
    Zhang, Jikai
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1589 - 1597
  • [5] Efficacy of the tetravalent protein COVID-19 vaccine, SCTV01E: a phase 3 double-blind, randomized, placebo-controlled trial
    Zhang, Ruizhi
    Zhao, Junshi
    Zhu, Xiaoping
    Guan, Qinghu
    Liu, Shujun
    Li, Meihong
    Gao, Jianghua
    Tan, Jie
    Cao, Feng
    Gan, Beifang
    Wu, Bo
    Bai, Jin
    Liu, Youquan
    Xie, Gang
    Liu, Chi
    Zhao, Wei
    Yan, Lixin
    Xu, Shuping
    Qian, Gui
    Liu, Dongfang
    Li, Jian
    Li, Wei
    Tian, Xuxin
    Wang, Jinling
    Wang, Shanshan
    Li, Dongyang
    Li, Jing
    Jiao, Yuhuan
    Li, Xuefeng
    Chen, Yuanxin
    Wang, Yang
    Gai, Wenlin
    Zhou, Qiang
    Xie, Liangzhi
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [6] Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial
    Shu, Ya-Jun
    He, Jian-Feng
    Pei, Rong-Juan
    He, Peng
    Huang, Zhu-Hang
    Chen, Shao-Min
    Ou, Zhi-Qiang
    Deng, Jing-Long
    Zeng, Pei-Yu
    Zhou, Jian
    Min, Yuan-Qin
    Deng, Fei
    Peng, Hua
    Zhang, Zheng
    Wang, Bo
    Xu, Zhong-Hui
    Guan, Wu-Xiang
    Hu, Zhong-Yu
    Zhang, Ji-Kai
    CHINESE MEDICAL JOURNAL, 2021, 134 (16) : 1967 - 1976
  • [7] Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial
    Shu Ya-Jun
    He Jian-Feng
    Pei Rong-Juan
    He Peng
    Huang Zhu-Hang
    Chen Shao-Min
    Ou Zhi-Qiang
    Deng Jing-Long
    Zeng Pei-Yu
    Zhou Jian
    Min Yuan-Qin
    Deng Fei
    Peng Hua
    Zhang Zheng
    Wang Bo
    Xu Zhong-Hui
    Guan Wu-Xiang
    Hu Zhong-Yu
    Zhang Ji-Kai
    中华医学杂志英文版, 2021, 134 (16) : 1967 - 1976
  • [8] Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
    Abarca, Katia
    Rey-Jurado, Emma
    Munoz-Durango, Natalia
    Vazquez, Yaneisi
    Soto, Jorge A.
    Galvez, Nicolas M. S.
    Valdes-Ferrada, Javier
    Iturriaga, Carolina
    Urzua, Marcela
    Borzutzky, Arturo
    Cerda, Jaime
    Villarroel, Luis
    Madrid, Victoria
    Gonzalez, Pablo A.
    Gonzalez-Aramundiz, Jose, V
    Bueno, Susan M.
    Kalergis, Alexis M.
    ECLINICALMEDICINE, 2020, 27
  • [9] Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial
    Jia, Siyue
    Shao, Chengwei
    Cheng, Xin
    Pan, Hongxing
    Wang, Zhijian
    Xia, Yu
    Xu, Jianfang
    Huai, Xuefen
    Leng, Danjing
    Wang, Jiarong
    Zhao, Gan
    Wang, Bin
    Li, Jingxin
    Zhu, Fengcai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [10] Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
    Yang, Shilong
    Li, Yan
    Dai, Lianpan
    Wang, Jianfeng
    He, Peng
    Li, Changgui
    Fang, Xin
    Wang, Chenfei
    Zhao, Xiang
    Huang, Enqi
    Wu, Changwei
    Zhong, Zaixin
    Wang, Fengze
    Duan, Xiaomin
    Tian, Siyu
    Wu, Lili
    Liu, Yan
    Luo, Yi
    Chen, Zhihai
    Li, Fangjun
    Li, Junhua
    Yu, Xian
    Ren, Hong
    Liu, Lihong
    Meng, Shufang
    Yan, Jinghua
    Hu, Zhongyu
    Gao, Lidong
    Gao, George F.
    LANCET INFECTIOUS DISEASES, 2021, 21 (08): : 1107 - 1119
12345